Glenn Sblendorio Iveric Bio, Inc. (ISEE) insider trading activity

Glenn Sblendorio is Chief Executive Officer of IVERIC bio, Inc.. Currently has a direct ownership of 0 shares of ISEE, which is worth approximately $0. The most recent transaction as insider was on Dec 27, 2021, when has been sold 5,229 shares (Common Stock) at a price of $16.64 per share, resulting in proceeds of $87,011. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

GLENN SBLENDORIO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 27 2021	SELL Open market or private sale	$87,011 $16.64 p/Share	5,229 Reduced 1.84%	279,133 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$7,582 $1.45 p/Share	5,229 Added 1.81%	284,362 Common Stock
Dec 23 2021	SELL Open market or private sale	$527,185 $16.96 p/Share	31,084 Reduced 8.4%	339,133 Common Stock
Dec 23 2021	SELL Bona fide gift	-	60,000 Reduced 17.69%	279,133 Common Stock
Dec 23 2021	BUY Exercise of conversion of derivative security	$68,385 $2.2 p/Share	31,084 Added 7.75%	370,217 Common Stock
Dec 22 2021	SELL Open market or private sale	$365,690 $16.5 p/Share	22,163 Reduced 6.13%	339,133 Common Stock
Dec 22 2021	BUY Exercise of conversion of derivative security	$32,136 $1.45 p/Share	22,163 Added 5.78%	361,296 Common Stock
Dec 20 2021	SELL Open market or private sale	$286,011 $15.44 p/Share	18,524 Reduced 5.18%	339,133 Common Stock
Dec 18 2021	BUY Exercise of conversion of derivative security	-	36,658 Added 9.3%	357,657 Common Stock
Dec 13 2021	SELL Open market or private sale	$122,239 $14.74 p/Share	8,293 Reduced 2.52%	320,999 Common Stock
Dec 12 2021	BUY Exercise of conversion of derivative security	-	22,950 Added 6.52%	329,292 Common Stock
Dec 09 2021	BUY Exercise of conversion of derivative security	-	23,750 Added 7.19%	306,342 Common Stock
Dec 12 2020	BUY Exercise of conversion of derivative security	-	22,950 Added 7.73%	273,773 Common Stock
Dec 09 2020	BUY Exercise of conversion of derivative security	-	23,750 Added 8.65%	250,823 Common Stock

Also insider at

ICPT

INTERCEPT PHARMACEUTICALS, INC. Healthcare

Director

FOLD

AMICUS THERAPEUTICS, INC. Healthcare

MLYS

Mineralys Therapeutics, Inc.

Director